無料プレビュー

Ionis Pharmaceuticals, Inc. (IONS) · NASDAQ Global Select

プロフィール

Ionis Pharmaceuticals is a biopharmaceutical company focused on discovering and developing RNA-targeted medicines using antisense oligonucleotide technology. The company offers seven marketed medicines treating serious diseases including familial chylomicronemia syndrome, hereditary angioedema, spinal muscular atrophy, and amyotrophic lateral sclerosis. Ionis operates as a fully integrated commercial-stage biotech company with independent and partnered launches, maintaining a late-stage pipeline in neurology, cardiometabolic diseases, and rare genetic conditions. The company manufactures most

主要指標

株価: $43.30 (-1.95%)
時価総額: 72億ドル
PER（今期予想）: -12.0
PBR: 16.3
配当利回り: —
52週レンジ: $42.63 – $86.74
業種: Healthcare / Biotechnology
上場: NASDAQ Global Select
構成銘柄: —

比較会社: VRTX Vertex Pharmaceuticals Incorporated、MRNA Moderna, Inc.、REGN Regeneron Pharmaceuticals, Inc.、ARGX argenx SE、SGEN Seagen Inc.、RVMD Revolution Medicines, Inc.、ONC BeOne Medicines AG、BIIB Biogen Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-04 · 更新: 2026-10-09